T1	Participants 729 857	Between 1995 and 1996, 100 patients were randomized to receive a prophylactic therapy for prevention of heterotopic ossification
T2	Participants 859 947	Forty-six patients were irradiated with 7 Gy single dose within 16-20 h before operation
T3	Participants 949 1076	Fifty-four patients were treated with nonsteroidal anti-inflammatory drugs (NSAID) (Voltaren resinat 2 x 75 mg/day for 2 weeks)
T4	Participants 1155 1318	One hundred patients receiving no prophylactic therapy after total hip arthroplasty between 1988 and 1992 were analyzed and defined as the historical control group
T5	Participants 84 154	prevention of heterotopic ossification following total hip replacement
